PROMO!First order? Get 10% OFF with this code: 1storder
PROMO!First order? Get 10% OFF with this code: 1storder
<ú<ø € EUR0.00 Cart
Home / CJC-1295 DAC / CJC-1295 DAC Pre-Mixed Peptide

CJC-1295 DAC Pre-Mixed Peptide

CJC-1295 with DAC is a long-acting synthetic peptide that promotes sustained growth hormone release by leveraging a Drug Affinity Complex for extended stability and effectiveness.

CJC-1295 DAC Pre-mixed Pen kit contains: 1 x CJC-1295 DAC 2mg Cartridge (premixed with Bacteriostatic Water), 1 x Cartridge Pen with 3 Pen Needle Tips, plus a Pen Carry Case.

Single CJC-1295 DAC Pre-mixed Cartridges: CJC-1295 DAC 2mg 1, 2 or 3 x Cartridge (premixed with Bacteriostatic Water) plus 3 Pen Needle Tips. (Single mixed cartridges do not contain the pen or case).

Price: Price range: 28.61€ through 77.24€

 Guaranteed High Purity +99% Pure
 New Customer Discount (code: 1storder) Get 10% off your first order
Description

Buy CJC-1295 DAC Pre-Mixed Peptide In Europe

Skip the prep with CJC-1295 DAC Pre-Mixed Peptide.
This ready-to-use, pre-blended formula arrives dosed and stable so you can move straight to research. Lab-verified with COA and shipped from EU stock for 48H delivery to UK, Germany, France and EU-wide.

Customers buy CJC-1295 DAC pre-mixed peptide for convenience and consistency. You can order CJC-1295 DAC ready-to-use online and purchase pre-blended CJC-1295 DAC with tracked EU dispatch.

Need to shop CJC-1295 DAC peptide or stock up on pre-mixed vials? We keep fresh batches on hand for fast, reliable service.

Buy CJC-1295 DAC Pre-Mixed Peptide In Europe

CJC-1295 DAC Pre-Mixed Peptide is a ready-to-use research formulation containing CJC-1295 with Drug Affinity Complex (DAC), a synthetic analogue of growth hormone-releasing hormone (GHRH). Unlike lyophilized peptide products that require reconstitution, this formulation is supplied in a pre-mixed solution according to the manufacturer’s specifications, allowing it to be used without additional preparation.

CJC-1295 DAC was developed to prolong the biological activity of GHRH through the addition of a Drug Affinity Complex (DAC), which enables reversible binding to serum albumin and extends the peptide’s half-life. Early clinical studies demonstrated sustained increases in circulating growth hormone (GH) and insulin-like growth factor-1 (IGF-1). However, CJC-1295 DAC has not been approved by major regulatory authorities, including the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), for routine therapeutic use. Evidence supporting its clinical use remains limited.


What Is CJC-1295 DAC Pre-Mixed Peptide?

CJC-1295 DAC Pre-Mixed Peptide is a manufacturer-prepared liquid formulation containing a predetermined concentration of CJC-1295 DAC. The product is intended for laboratory research or other manufacturer-specified purposes and is supplied in a ready-to-use format.

Common characteristics include:

  • Ready-to-use liquid formulation
  • Contains CJC-1295 with Drug Affinity Complex (DAC)
  • Manufacturer-labeled peptide concentration
  • Quality-controlled manufacturing
  • Sterile packaging where applicable
  • Batch and lot identification
  • Available in various vial sizes depending on the manufacturer

Features of CJC-1295 DAC Pre-Mixed Peptide

Key features may include:

  • Pre-mixed formulation requiring no reconstitution
  • Clearly labeled peptide concentration
  • Secure sterile vial packaging
  • Quality-controlled production
  • Batch traceability
  • Manufacturer-specific storage recommendations
  • Available in multiple strengths depending on the supplier

Research Background of CJC-1295 DAC Pre-Mixed Peptide

CJC-1295 DAC is a modified analogue of growth hormone-releasing hormone designed to stimulate endogenous growth hormone secretion. The addition of the Drug Affinity Complex allows the peptide to bind reversibly to circulating albumin, significantly extending its duration of action compared with shorter-acting GHRH analogues.

Early placebo-controlled human studies demonstrated that a single administration of CJC-1295 DAC produced sustained elevations of growth hormone for several days and increased circulating IGF-1 concentrations for up to approximately 10–14 days. These pharmacological properties have made the peptide an important subject of endocrine and metabolic research. Nevertheless, additional high-quality clinical studies are needed to establish long-term safety and clinical effectiveness.


Potential Research Applications of CJC-1295 DAC Pre-Mixed Peptide

Published scientific research has explored CJC-1295 DAC in:

  • Growth hormone physiology
  • Endocrine system research
  • IGF-1 regulation
  • Hormonal signaling studies
  • Metabolic biology
  • Exercise physiology research
  • Laboratory and scientific investigations

These applications remain investigational and should not be interpreted as approved medical indications.


Storage Guidelines for CJC-1295 DAC Pre-Mixed Peptide

To help preserve product quality:

  • Store according to the manufacturer’s recommendations.
  • Keep the vial in its original packaging.
  • Protect from excessive heat, moisture, and direct sunlight.
  • Refrigerate if recommended by the manufacturer.
  • Do not freeze unless specifically instructed.
  • Do not use if the vial is damaged or leaking.
  • Keep out of the reach of children.

Always follow the storage recommendations provided with the product.


Safety Information for CJC-1295 DAC Pre-Mixed Peptide

Important precautions include:

  • Use only according to the manufacturer’s labeling.
  • Handle using appropriate laboratory procedures where applicable.
  • Do not use if the seal has been broken or contamination is suspected.
  • Follow recommended storage conditions.
  • Consult qualified healthcare professionals regarding appropriate handling.

CJC-1295 DAC Pre-Mixed Peptide remains an investigational compound. Its safety and effectiveness for routine therapeutic use have not been established, and it has not received approval from major regulatory authorities for general medical use.


Disposal of CJC-1295 DAC Pre-Mixed Peptide

After use or when expired:

  • Dispose of the product according to local regulations.
  • Do not reuse single-use containers.
  • Discard damaged or expired vials appropriately.
  • Follow institutional procedures for laboratory or pharmaceutical waste disposal.

Frequently Asked Questions About CJC-1295 DAC Pre-Mixed Peptide

What is CJC-1295 DAC Pre-Mixed Peptide?

CJC-1295 DAC Pre-Mixed Peptide is a ready-to-use liquid formulation containing the investigational peptide CJC-1295 with Drug Affinity Complex (DAC), supplied for laboratory research or other manufacturer-specified purposes.

What is CJC-1295 DAC Pre-Mixed Peptide used for?

CJC-1295 DAC Pre-Mixed Peptide is intended for laboratory research involving growth hormone physiology, endocrine signaling, IGF-1 regulation, metabolic biology, and related scientific investigations. It is not approved for routine medical treatment.

How should CJC-1295 DAC Pre-Mixed Peptide be stored?

CJC-1295 DAC Pre-Mixed Peptide should be stored according to the manufacturer’s recommendations, which may include refrigeration and protection from excessive heat, moisture, and direct sunlight to help maintain product stability.


Further Reading

For additional evidence-based information about CJC-1295 DAC and peptide research:


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: Products are supplied for research purposes only and are not intended to diagnose, treat, cure, or prevent any disease.